- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有658家主力机构披露2025-06-30报告期持股数据，持仓量总计2.62亿股，占流通A股46.27%
- 波段诊断：
-
技术面诊股
诊断结果：7.6技术面打败了83%的股票
技术面评分前10的股票
近期的平均成本为59.62元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为59.62元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"59.62","date":1761812916,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。
[{"date":"2025.10.31","stock":"1.34","trade":"2.36","ind":"-1.14"},{"date":"2025.10.30","stock":"-0.66","trade":"-1.20","ind":"-1.16"},{"date":"2025.10.29","stock":"11.09","trade":"2.22","ind":"1.95"},{"date":"2025.10.28","stock":"0.32","trade":"-0.53","ind":"-0.44"},{"date":"2025.10.27","stock":"1.54","trade":"1.02","ind":"1.51"},{"date":"2025.10.24","stock":"-0.13","trade":"1.41","ind":"2.02"},{"date":"2025.10.23","stock":"-1.11","trade":"-0.34","ind":"0.22"},{"date":"2025.10.22","stock":"-0.89","trade":"-0.68","ind":"-0.62"},{"date":"2025.10.21","stock":"-0.70","trade":"1.23","ind":"2.06"},{"date":"2025.10.20","stock":"0.95","trade":"1.65","ind":"0.98"},{"date":"2025.10.17","stock":"-1.69","trade":"-2.01","ind":"-3.04"},{"date":"2025.10.16","stock":"-1.05","trade":"-0.65","ind":"-0.25"},{"date":"2025.10.15","stock":"2.51","trade":"2.81","ind":"1.73"},{"date":"2025.10.14","stock":"-1.16","trade":"-1.72","ind":"-2.54"},{"date":"2025.10.13","stock":"-2.28","trade":"-1.52","ind":"-0.93"},{"date":"2025.10.10","stock":"-2.27","trade":"-2.09","ind":"-2.70"},{"date":"2025.10.09","stock":"-1.88","trade":"-0.06","ind":"1.47"},{"date":"2025.09.30","stock":"-1.21","trade":"1.51","ind":"0.35"},{"date":"2025.09.29","stock":"-0.98","trade":"0.13","ind":"2.05"},{"date":"2025.09.26","stock":"-2.32","trade":"-2.13","ind":"-1.76"},{"date":"2025.09.25","stock":"-0.49","trade":"0.08","ind":"0.67"}]
泰格医药,深证成指,医疗服务指数
压力支撑
该股压力位为58.96元，支撑位为57.59元。
[{"text":"\u538b\u529b\u4f4d","value":"58.96","date":1761840000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"57.59","date":1761840000,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.6资金面打败了22%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体无进出。
更新时间：10月31日 20:34
| 机构今日流向(万元) | 3473.92 | 机构5日流向(万元) | -686.67 |
| 机构10日流向(万元) | -2.40 | 机构20日流向(万元) | -12955.83 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少481.32万股，其中基金净减仓119家，主力净增仓28家，暂未发现中长期投资价值。
截止2025-06-30，共658家主力机构（基金656家，一般法人1家，社保基金1家），持仓量总计26196.82万股，占流通A股46.27%
其中，基金持仓与2024-12-31相比：
增仓：108家 ，增持 1832.61万股
减仓：227家 ，减持 3309.00万股
新出现在主力名单中：266家 ，持有3581.62万股
从主力名单中消失：238家 ，原持有2878.7万股
其中，基金持仓与2024-12-31相比：
增仓：108家 ，增持 1832.61万股
减仓：227家 ，减持 3309.00万股
新出现在主力名单中：266家 ，持有3581.62万股
从主力名单中消失：238家 ，原持有2878.7万股
消息面诊股
诊断结果：5.5消息面打败了32%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 机构评级|华兴证券给予泰格医药“买入”评级
2025-10-31 - 方正证券：医药生物业新一轮上行已经开始 重视早研C
2025-10-31 - 泰格医药：10月30日获融资买入7566.42万元
2025-10-31 - 里昂：维持泰格医药跑赢大市评级 第三季度温和复苏
2025-10-30 - 港股CRO公司走势分化 方达控股一度涨逾13%
2025-10-30 - 泰格医药涨超7% 三季度归母净利同比增长98.73
2025-10-30 - 泰格医药：10月29日持仓该股ETF资金净流入40
2025-10-30 - 泰格医药：10月29日获融资买入1.35亿元
2025-10-30 - 午后异动！300274，猛拉涨超17%，市值突破4
2025-10-29 - 创新药概念股午后持续拉升，诺思格20cm涨停
2025-10-29
消息列表
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-29 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-09-09 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-29 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-07-18 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-15 |
| 利好 | 分红转增 | 10派3元(含税) | 2025-03-28 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-03-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-28 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-01-24 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：7.2行业面打败了95%的股票
医疗服务行业最新资金流向
近10日来该行业走势明显向上，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，接近大盘。
[{"date":"2025.10.31","price":"-1.14","value":"2.36"},{"date":"2025.10.30","price":"-1.16","value":"-1.20"},{"date":"2025.10.29","price":"1.95","value":"2.22"},{"date":"2025.10.28","price":"-0.44","value":"-0.53"},{"date":"2025.10.27","price":"1.51","value":"1.02"},{"date":"2025.10.24","price":"2.02","value":"1.41"},{"date":"2025.10.23","price":"0.22","value":"-0.34"},{"date":"2025.10.22","price":"-0.62","value":"-0.68"},{"date":"2025.10.21","price":"2.06","value":"1.23"},{"date":"2025.10.20","price":"0.98","value":"1.65"},{"date":"2025.10.17","price":"-3.04","value":"-2.01"},{"date":"2025.10.16","price":"-0.25","value":"-0.65"},{"date":"2025.10.15","price":"1.73","value":"2.81"},{"date":"2025.10.14","price":"-2.54","value":"-1.72"},{"date":"2025.10.13","price":"-0.93","value":"-1.52"},{"date":"2025.10.10","price":"-2.70","value":"-2.09"},{"date":"2025.10.09","price":"1.47","value":"-0.06"},{"date":"2025.09.30","price":"0.35","value":"1.51"},{"date":"2025.09.29","price":"2.05","value":"0.13"},{"date":"2025.09.26","price":"-1.76","value":"-2.13"},{"date":"2025.09.25","price":"0.67","value":"0.08"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 诺思格 | 29.61% | 36.72% | 6.2分 |
| 2 | 创新医疗 | 24.05% | 11.44% | 6.3分 |
| 3 | - | 17.06% | 32.05% | 分 |
| 4 | 美年健康 | 11.71% | 9.96% | 6.1分 |
| 5 | 普蕊斯 | 10.51% | 20.85% | 6.4分 |
| 6 | 诚达药业 | 10.10% | -0.15% | 4.8分 |
| 8 | 三博脑科 | 7.41% | 6.23% | 5.7分 |
| 10 | 光正眼科 | 6.09% | 0.00% | 6.2分 |
| 12 | 兰卫医学 | 4.66% | 2.22% | 5.8分 |
| 14 | ST中珠 | 3.59% | -1.94% | 5.1分 |
| 16 | 澳洋健康 | 3.37% | 0.94% | 5.9分 |
| 18 | 万邦医药 | 2.93% | -0.16% | 5.2分 |
| 20 | 九洲药业 | 2.57% | 3.53% | 6.2分 |
| 22 | 普瑞眼科 | 1.16% | 3.28% | 5.7分 |
| 24 | 贝瑞基因 | 0.69% | 2.27% | 5.5分 |
| 26 | 金域医学 | 0.44% | 5.84% | 6.3分 |
| 28 | 百花医药 | -0.44% | -1.86% | 5.9分 |
| 30 | 华大基因 | -0.77% | 2.89% | 5.4分 |
| 32 | 爱尔眼科 | -1.13% | 0.25% | 6.1分 |
| 34 | 泰格医药 | -1.35% | 13.93% | 6.1分 |
| 36 | 国际医学 | -1.64% | -1.44% | 5.7分 |
| 38 | 毕得医药 | -2.78% | 0.47% | 6.2分 |
| 40 | 昭衍新药 | -3.42% | 13.99% | 6.9分 |
| 42 | 南模生物 | -3.89% | 2.22% | 6.5分 |
| 44 | 益诺思 | -4.32% | 10.39% | 6.7分 |
| 46 | 诺禾致源 | -5.86% | 0.48% | 6.1分 |
| 48 | 药康生物 | -6.70% | 1.14% | 6.7分 |
| 50 | 华康洁净 | -11.45% | -14.48% | 4.6分 |
| 52 | 皓宸医疗 | -13.05% | 0.60% | 5.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 15/101 ， 34/101。
[{"date":"2025-09-30","value":"4.88","vol":"3.15"},{"date":"2025-06-30","value":"1.86","vol":"2.23"},{"date":"2025-03-31","value":"0.80","vol":"0.92"},{"date":"2024-12-31","value":"1.94","vol":"-0.15"},{"date":"2024-09-30","value":"3.87","vol":"3.24"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.88 | 1.86 | 0.80 | 1.94 | 3.87 |
| 行业(%) | 3.15 | 2.23 | 0.92 | -0.15 | 3.24 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"29.16","vol":"35.90"},{"date":"2025-06-30","value":"30.09","vol":"36.06"},{"date":"2025-03-31","value":"30.03","vol":"34.67"},{"date":"2024-12-31","value":"33.95","vol":"34.77"},{"date":"2024-09-30","value":"38.88","vol":"36.16"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
29.16 | 30.09 | 30.03 | 33.95 | 38.88 |
| 行业(%) | 35.90 | 36.06 | 34.67 | 34.77 | 36.16 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 31/101 ， 23/101。
[{"date":"2025-09-30","value":"-0.82","vol":"2.47"},{"date":"2025-06-30","value":"-3.21","vol":"2.42"},{"date":"2025-03-31","value":"-5.79","vol":"-0.08"},{"date":"2024-12-31","value":"-10.58","vol":"-0.73"},{"date":"2024-09-30","value":"-10.32","vol":"0.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-0.82 | -3.21 | -5.79 | -10.58 | -10.32 |
| 行业(%) | 2.47 | 2.42 | -0.08 | -0.73 | 0.87 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"25.45","vol":"15.81"},{"date":"2025-06-30","value":"-22.22","vol":"-71.46"},{"date":"2025-03-31","value":"-29.61","vol":"-25.93"},{"date":"2024-12-31","value":"-79.99","vol":"-96.53"},{"date":"2024-09-30","value":"-56.72","vol":"-161.08"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
25.45 | -22.22 | -29.61 | -79.99 | -56.72 |
| 行业(%) | 15.81 | -71.46 | -25.93 | -96.53 | -161.08 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 43/101 ， 2/101。
[{"date":"2025-09-30","value":"0.17","vol":"0.31"},{"date":"2025-06-30","value":"0.11","vol":"0.20"},{"date":"2025-03-31","value":"0.05","vol":"0.10"},{"date":"2024-12-31","value":"0.23","vol":"0.41"},{"date":"2024-09-30","value":"0.17","vol":"0.31"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.17 | 0.11 | 0.05 | 0.23 | 0.17 |
| 行业(次) | 0.31 | 0.20 | 0.10 | 0.41 | 0.31 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"93.82","vol":"11.36"},{"date":"2025-06-30","value":"60.13","vol":"7.41"},{"date":"2025-03-31","value":"31.99","vol":"3.76"},{"date":"2024-12-31","value":"157.57","vol":"16.35"},{"date":"2024-09-30","value":"135.87","vol":"14.25"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
93.82 | 60.13 | 31.99 | 157.57 | 135.87 |
| 行业(次) | 11.36 | 7.41 | 3.76 | 16.35 | 14.25 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"18.64","vol":"16.21"},{"date":"2025-06-30","value":"12.49","vol":"15.87"},{"date":"2025-03-31","value":"12.65","vol":"-1.69"},{"date":"2024-12-31","value":"33.75","vol":"22.34"},{"date":"2024-09-30","value":"23.48","vol":"12.23"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 18.64 | 12.49 | 12.65 | 33.75 | 23.48 |
| 行业 | 16.21 | 15.87 | -1.69 | 22.34 | 12.23 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.55","vol":"0.94"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.98","vol":"1.31"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.55 | - | 0.98 | - |
| 行业 | 0.00 | 0.94 | 0.00 | 1.31 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 6/101 ， 26/101。
[{"date":"2025-09-30","value":"2.16","vol":"3.81"},{"date":"2025-06-30","value":"1.83","vol":"3.69"},{"date":"2025-03-31","value":"1.62","vol":"3.84"},{"date":"2024-12-31","value":"1.72","vol":"3.70"},{"date":"2024-09-30","value":"1.37","vol":"4.11"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.16 | 1.83 | 1.62 | 1.72 | 1.37 |
| 行业 | 3.81 | 3.69 | 3.84 | 3.70 | 4.11 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.08","vol":"3.06"},{"date":"2025-06-30","value":"1.76","vol":"2.98"},{"date":"2025-03-31","value":"1.56","vol":"3.12"},{"date":"2024-12-31","value":"1.66","vol":"3.01"},{"date":"2024-09-30","value":"1.32","vol":"3.38"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.08 | 1.76 | 1.56 | 1.66 | 1.32 |
| 行业 | 3.06 | 2.98 | 3.12 | 3.01 | 3.38 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 43/101 ， 42/101。
[{"date":"2025-09-30","value":"14.16","vol":"31.72"},{"date":"2025-06-30","value":"15.93","vol":"32.65"},{"date":"2025-03-31","value":"16.78","vol":"32.24"},{"date":"2024-12-31","value":"16.07","vol":"32.31"},{"date":"2024-09-30","value":"19.35","vol":"31.03"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
14.16 | 15.93 | 16.78 | 16.07 | 19.35 |
| 行业(%) | 31.72 | 32.65 | 32.24 | 32.31 | 31.03 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.19","vol":"0.91"},{"date":"2025-06-30","value":"0.22","vol":"0.95"},{"date":"2025-03-31","value":"0.23","vol":"0.98"},{"date":"2024-12-31","value":"0.22","vol":"1.01"},{"date":"2024-09-30","value":"0.28","vol":"0.85"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.19 | 0.22 | 0.23 | 0.22 | 0.28 |
| 行业(%) | 0.91 | 0.95 | 0.98 | 1.01 | 0.85 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 西部证券 | 2025-10-29 | 买入 | |
| 中信建投证券 | 2025-09-17 | 买入 | |
| 财信证券 | 2025-09-01 | 买入 | |
| 光大证券 | 2025-08-31 | 增持 | |
| 东莞证券 | 2025-08-29 | 买入 | |
| 野村东方国际证券 | 2025-08-29 | 中性 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"28.74","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"20.07","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"20.25","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"4.05","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"11.18","blueLineValue":"1.29","type":"YC"}]